1. Resveratrol enhances the radiosensitivity of nasopharyngeal carcinoma cells by downregulating E2F1
   Yuhui Tan et al, 2017, Oncology Reports CrossRef
2. Silencing vascular endothelial growth factor C increases the radiosensitivity in nasopharyngeal carcinoma CNE‐2 cells
   Feng Wang et al, 2020, Journal of Cellular Biochemistry CrossRef
3. Combined chemotherapy plus endostar with sequential stereotactic radiotherapy as salvage treatment for recurrent esophageal cancer with severe dyspnea: A case report and review of the literature
   MINGFANG XU et al, 2014, Oncology Letters CrossRef
4. Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer
   Charnay Cunningham et al, 2023, Pharmaceuticals CrossRef
5. Metformin inhibits the growth of nasopharyngeal carcinoma cells and sensitizes the cells to radiation via inhibition of the DNA damage repair pathway
   HAIWEN LI et al, 2014, Oncology Reports CrossRef
6. A phase II multicenter randomized controlled trial to compare standard chemoradiation with or without recombinant human endostatin injection (Endostar) therapy for the treatment of locally advanced nasopharyngeal carcinoma: Long-term outcomes update
   Yuanyuan Li et al, 2020, Current Problems in Cancer CrossRef
7. Critical Role of Aberrant Angiogenesis in the Development of Tumor Hypoxia and Associated Radioresistance
   Gabriele Multhoff et al, 2014, Cancers CrossRef
8. Intensity-modulated radiotherapy combined with endostar has similar efficacy but weaker acute adverse reactions than IMRT combined with chemotherapy in the treatment of locally advanced nasopharyngeal carcinoma
   Min Kang et al, 2018, Medicine CrossRef
9. Recombined humanized endostatin (Endostar) intravenous infusion in the treatment of refractory nasopharyngeal carcinoma
   Chen Chen et al, 2019, Medicine CrossRef
10. Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
    Yuanxiu Yin et al, 2022, Radiation Oncology CrossRef
11. Nano-Targeting of Thyrointegrin αvβ3 Receptor in Solid Tumors and Impact on Radiosensitization
    Thangirala Sudha et al, 2021, Radiation Research CrossRef
12. A Phase II Trial of Endostar Combined With Gemcitabine and Cisplatin Chemotherapy in Patients With Metastatic Nasopharyngeal Carcinoma (NCT01612286)
    Ting Jin et al, 2014, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
13. Long Non-Coding RNA LINC00202 Enhances Radiotherapy Sensitivity of Nasopharyngeal Carcinoma by Regulating Ras and Rab Interactor 1
    Chuanyun Yu et al, 2023, Journal of Biomedical Nanotechnology CrossRef
14. In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma
    YanXin Yu et al, 2017, Drug Delivery CrossRef
15. Performance of Pretreatment MRI-Based Radiomics in Recombinant Human Endostatin Plus Concurrent Chemoradiotherapy Response Prediction in Nasopharyngeal Carcinoma: A Retrospective Study
    Lixuan Huang et al, 2023, Technology in Cancer Research & Treatment CrossRef
16. The Treatment Combining Antiangiogenesis with Chemoradiotherapy Impinges on the Peripheral Circulation Vascular Endothelial Cells and Therapeutic Effect in the Patients with Locally Advanced Nasopharyngeal Carcinoma
    Xiuyun Gong et al, 2022, BioMed Research International CrossRef
17. PDGFR-β inhibitor slows tumor growth but increases metastasis in combined radiotherapy and Endostar therapy
    Limei Yin et al, 2018, Biomedicine & Pharmacotherapy CrossRef
18. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
    Holly E. Barker et al, 2015, Nature Reviews Cancer CrossRef